AmerisourceBergen Corp. (ABC) Insider Sells $536,928.26 in Stock
AmerisourceBergen Corp. (NYSE:ABC) insider John G. Chou sold 6,974 shares of the stock in a transaction dated Tuesday, January 15th. The stock was sold at an average price of $76.99, for a total transaction of $536,928.26. Following the completion of the transaction, the insider now directly owns 58,759 shares of the company’s stock, valued at $4,523,855.41. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of ABC opened at $79.86 on Friday. The stock has a market capitalization of $16.12 billion, a price-to-earnings ratio of 11.74, a price-to-earnings-growth ratio of 1.21 and a beta of 1.08. The company has a debt-to-equity ratio of 1.48, a quick ratio of 0.50 and a current ratio of 0.93. AmerisourceBergen Corp. has a fifty-two week low of $69.36 and a fifty-two week high of $106.27.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $1.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.44 by $0.01. The business had revenue of $43.30 billion for the quarter, compared to analysts’ expectations of $43.27 billion. AmerisourceBergen had a net margin of 0.99% and a return on equity of 45.54%. The business’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.33 earnings per share. As a group, equities analysts predict that AmerisourceBergen Corp. will post 6.79 earnings per share for the current year.
A number of equities analysts recently issued reports on ABC shares. UBS Group started coverage on shares of AmerisourceBergen in a research note on Thursday. They issued a “buy” rating and a $89.00 price target for the company. TheStreet downgraded shares of AmerisourceBergen from a “b-” rating to a “c+” rating in a research note on Tuesday, January 8th. Morgan Stanley increased their price target on shares of AmerisourceBergen from $88.00 to $91.00 and gave the stock an “equal weight” rating in a research note on Monday, December 3rd. Zacks Investment Research upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Thursday, November 22nd. Finally, Royal Bank of Canada set a $90.00 price objective on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Wednesday, November 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $99.00.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://theolympiareport.com/2019/01/19/amerisourcebergen-corp-abc-insider-sells-536928-26-in-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Article: What is a balanced fund?
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.